10. In 2023, a company will produce two batches of drug product that will be used in Phase I clinical trials. If the Phase I trials are successful, the company will produce five more batches of drug product in 2025 for use in Phase II clinical trials. Assuming the company wants to utilize the least number of personnel, identify the department responsible for approving/releasing each batch during each campaign